Literature DB >> 32050243

Severe corneal melting after cataract surgery in patients prescribed topical postoperative NSAIDs and dexamethasone/neomycin combination therapy.

Emily Cabourne1, Nicola Lau, Declan Flanagan, Julie Nott, Jill Bloom, Romesh Angunawela.   

Abstract

Three patients using a postoperative combination of topical ketorolac (Acular) and neomycin/polymyxin B sulfate/dexamethasone (Maxitrol) were diagnosed with atypical keratopathy soon after routine cataract surgery. An immediate retrospective analysis of hospital patients who had used this topical drug combination in the previous year identified 10 other patients who also had significant corneal pathology after uneventful cataract surgery. Five of the 13 affected patients had corneal melting and 1 patient had corneal perforation and endophthalmitis. At the last recorded follow-up appointment, 8 of the 13 patients had a visual acuity of 6/36 or worse. Corneal melting is a rare complication of topical nonsteroidal anti-inflammatory drugs (NSAIDs). We propose that the combined use of topical NSAIDs and other agents, such as neomycin and benzalkonium, that further compromise the corneal epithelium, should be used with vigilance and increased awareness of potential keratopathy and permanent visual morbidity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32050243     DOI: 10.1016/j.jcrs.2019.08.033

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  Intraoperative subconjunctival steroid reduces the incidence of pseudophakic macular oedema: a cohort study of 20,066 consecutive phacoemulsification surgeries.

Authors:  Michelle Ai Ling Teo; Edward Bloch; Ramu Muniraju; Paul Ursell
Journal:  Eye (Lond)       Date:  2022-10-22       Impact factor: 4.456

2.  Prophylactic Use of Nonsteroidal Anti-Inflammatory Drugs after Cataract Surgery and Corneal Melt.

Authors:  Zahra Ashena; Mayank A Nanavaty; Ahmed S Bardan; Riddhi Thaker; Lucia Bascaran
Journal:  J Curr Ophthalmol       Date:  2022-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.